Novo Integrated Sciences Statistics
Total Valuation
Novo Integrated Sciences has a market cap or net worth of 789,210. The enterprise value is 5.65 million.
| Market Cap | 789,210 |
| Enterprise Value | 5.65M |
Important Dates
The last earnings date was Friday, December 20, 2024.
| Earnings Date | Dec 20, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Novo Integrated Sciences has 19.73 million shares outstanding. The number of shares has increased by 77.38% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 19.73M |
| Shares Change (YoY) | +77.38% |
| Shares Change (QoQ) | +2.01% |
| Owned by Insiders (%) | 7.73% |
| Owned by Institutions (%) | 5.53% |
| Float | 18.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.05 |
| PB Ratio | 0.05 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.35 |
| EV / Sales | 0.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.11 |
Financial Position
The company has a current ratio of 0.37, with a Debt / Equity ratio of 0.41.
| Current Ratio | 0.37 |
| Quick Ratio | 0.19 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.18 |
| Interest Coverage | -1.15 |
Financial Efficiency
Return on equity (ROE) is -82.47% and return on invested capital (ROIC) is -20.97%.
| Return on Equity (ROE) | -82.47% |
| Return on Assets (ROA) | -15.35% |
| Return on Capital (ROIC) | -20.97% |
| Revenue Per Employee | 69,970 |
| Profits Per Employee | -85,088 |
| Employee Count | 230 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 7.17 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.42% in the last 52 weeks. The beta is -0.66, so Novo Integrated Sciences's price volatility has been lower than the market average.
| Beta (5Y) | -0.66 |
| 52-Week Price Change | -97.42% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.43 |
| Relative Strength Index (RSI) | 37.83 |
| Average Volume (20 Days) | 115,020 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, Novo Integrated Sciences had revenue of 13.29 million and -16.17 million in losses. Loss per share was -0.90.
| Revenue | 13.29M |
| Gross Profit | 5.74M |
| Operating Income | -8.31M |
| Pretax Income | -16.13M |
| Net Income | -16.17M |
| EBITDA | -6.05M |
| EBIT | -8.31M |
| Loss Per Share | -0.90 |
Balance Sheet
The company has 844,584 in cash and 5.98 million in debt, giving a net cash position of -5.14 million or -0.26 per share.
| Cash & Cash Equivalents | 844,584 |
| Total Debt | 5.98M |
| Net Cash | -5.14M |
| Net Cash Per Share | -0.26 |
| Equity (Book Value) | 14.61M |
| Book Value Per Share | 0.78 |
| Working Capital | -9.16M |
Cash Flow
In the last 12 months, operating cash flow was -5.07 million and capital expenditures -5,034, giving a free cash flow of -5.07 million.
| Operating Cash Flow | -5.07M |
| Capital Expenditures | -5,034 |
| Free Cash Flow | -5.07M |
| FCF Per Share | -0.26 |
Margins
Gross margin is 43.20%, with operating and profit margins of -62.54% and -121.61%.
| Gross Margin | 43.20% |
| Operating Margin | -62.54% |
| Pretax Margin | -121.32% |
| Profit Margin | -121.61% |
| EBITDA Margin | -45.53% |
| EBIT Margin | -62.54% |
| FCF Margin | n/a |
Dividends & Yields
Novo Integrated Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -77.38% |
| Shareholder Yield | -77.38% |
| Earnings Yield | -2,241.39% |
| FCF Yield | -643.03% |
Stock Splits
The last stock split was on November 7, 2023. It was a reverse split with a ratio of 0.1.
| Last Split Date | Nov 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
Novo Integrated Sciences has an Altman Z-Score of -3.72. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.72 |
| Piotroski F-Score | n/a |